SARS-CoV-2 epidemiology, prevention, risk factors, evaluation, diagnosis, management and vaccines

  • Moneer Al-Nabolsi, DO Beaumont Hospital – Farmington Hills – Family Medicine, Farmington Hills, MI
  • Dalia Alhusein, DO Beaumont Hospital – Farmington Hills – Family Medicine, Farmington Hills, MI
  • Tiffany Marchewka, DO Beaumont Hospital – Farmington Hills – Family Medicine, Farmington Hills, MI
  • Molly Kucera, DO Beaumont Hospital – Farmington Hills – Family Medicine, Farmington Hills, MI
  • Ali Daher, DO Beaumont Hospital – Farmington Hills – Family Medicine, Farmington Hills, MI
  • Rohan Venida, DO Beaumont Hospital – Farmington Hills – Family Medicine, Farmington Hills, MI
  • Alhan Beydoun, DO Beaumont Hospital – Farmington Hills – Family Medicine, Farmington Hills, MI
  • Rushi Surati, DO Beaumont Hospital – Farmington Hills – Family Medicine, Farmington Hills, MI
  • Abigail Deland, DO Beaumont Hospital – Farmington Hills – Family Medicine, Farmington Hills, MI
  • Matthew Sebastian, DO Beaumont Hospital – Farmington Hills – Family Medicine, Farmington Hills, MI

Abstract

What we have learned about COVID-19 is ongoing as research continues to evolve. This article will serve to provide a succinct, comprehensive overview of SARS-CoV-2 with respect to epidemiology, risk factors, prevention, presentation, management and vaccinations.

Published
2021-09-01
How to Cite
Al-Nabolsi, M., D. Alhusein, T. Marchewka, M. Kucera, A. Daher, R. Venida, A. Beydoun, R. Surati, A. Deland, and M. Sebastian. “SARS-CoV-2 Epidemiology, Prevention, Risk Factors, Evaluation, Diagnosis, Management and Vaccines”. Osteopathic Family Physician, Vol. 13, no. 5, Sept. 2021, pp. 31–37, doi:10.33181/13050.